pIRESneo3哺乳动物表达载体说明

pIRESneo3

编号

北京华越洋生物VECT6018

pIRESneo 3载体基本信息

载体名称: 质粒类型: 启动子: 表达水平: 克隆方法: 载体大小: 5' 测序引物: 5' 测序引物序列: 3' 测序引物: 3' 测序引物序列:

载体标签: 载体抗性: 筛选标记: 克隆菌株: 宿主细胞(系):

备注: 稳定性: 组成型: 病毒/非病毒:

载体名称

pIRESneo3

pIRESneo3, pIRESneo 3 哺乳动物细胞表达载体 CMV 高

多克隆位点,限制性内切酶 5260bp CMV-F

5'-CGCAAATGGGCGGTAGGCGTG-3' pIRESrv

5'-GCCCTAGATGCATGCTCG-3' 无

氨苄青霉素(Ampicillin ) 新霉素(Neomycin ) DH5α, HB101

常规细胞系,293、CV-1、

CHO 等

pIRESneo3 contains the internal ribosome entry site (IRES) of the encephalomyocarditis virus (ECMV), which permits the translation of two open reading frames from one messenger RNA. 稳表达 或 瞬表达 组成型 非病毒

pIRESneo 3载体质粒图谱和多克隆位点信息

pIRESneo 3载体简介

Description: pIRESneo3

contains

the

internal

ribosome

entry

site

(IRES)

of

the

encephalomyocarditis virus (ECMV), which permits the translation of two open reading frames from one messenger RNA (1–3). After selection with G418, nearly all surviving colonies will stably express the gene of interest, thus decreasing the need to screen large numbers of colonies to find functional clones. To select for cells that express high levels of the gene of interest, the selective pressure for antibiotic resistance was increased by shifting the neomycin phosphotransferase gene downstream to a less optimal position for translation as directed by the IRES sequence (1). By decreasing the level of expression of the antibiotic resistance marker, the selective pressure on the entire expression cassette is increased, resulting in the selection of cells that express the entire transcript, including the gene of interest, at high levels.

The expression cassette of pIRESneo3 contains the human cytomegalovirus (CMV) major immediate early promoter/enhancer followed by a multiple cloning site (MCS) that precedes stop codons in all three reading frames, a synthetic intron known to enhance the stability of the mRNA (4), the ECMV IRES followed by the neomycin phosphotransferase (NPT II) gene, and the polyadenylation signal from SV40. Ribosomes can enter the bicistronic mRNA at the 5' end to translate the gene of interest and at the ECMV IRES to translate the antibiotic resistance marker. Use:

When using the pIRESneo3 Vector, the antibiotic exerts selective pressure on the entire expression cassette; thus, a high dose of antibiotic will select for cells expressing a high level of the gene of interest. This selective pressure also ensures that the expression of the gene of interest will be stable over time in culture. Unless your expression experiments require a pure population of cells, you can use the pool of cells surviving selection instead of isolating and characterizing clonal cell lines. We recommend selecting mammalian cultures in 500–1,300 µg/ml G418 (Cat. No. 631307) depending

on the cell line. Be sure to establish a kill curve for each cell line and each lot of G418 to determine optimal selection concentration.

pIRESneo 3载体序列

ORIGIN

1 GACGGATCGG GAGATCTCCC GATCCCCTAT GGTCGACTCT CAGTACAATC TGCTCTGATG 61 CCGCATAGTT AAGCCAGTAT CTGCTCCCTG CTTGTGTGTT GGAGGTCGCT GAGTAGTGCG 121 CGAGCAAAAT TTAAGCTACA ACAAGGCAAG GCTTGACCGA CAATTGCATG AAGAATCTGC 181 TTAGGGTTAG GCGTTTTGCG CTGCTTCGCG ATGTACGGGC CAGATATACG CGTTGACATT 241 GATTATTGAC TAGTTATTAA TAGTAATCAA TTACGGGGTC ATTAGTTCAT AGCCCATATA 301 TGGAGTTCCG CGTTACATAA CTTACGGTAA ATGGCCCGCC TGGCTGACCG CCCAACGACC 361 CCCGCCCATT GACGTCAATA ATGACGTATG TTCCCATAGT AACGCCAATA GGGACTTTCC 421 ATTGACGTCA ATGGGTGGAC TATTTACGGT AAACTGCCCA CTTGGCAGTA CATCAAGTGT 481 ATCATATGCC AAGTACGCCC CCTATTGACG TCAATGACGG TAAATGGCCC GCCTGGCATT 541 ATGCCCAGTA CATGACCTTA TGGGACTTTC CTACTTGGCA GTACATCTAC GTATTAGTCA 601 TCGCTATTAC CATGGTGATG CGGTTTTGGC AGTACATCAA TGGGCGTGGA TAGCGGTTTG 661 ACTCACGGGG ATTTCCAAGT CTCCACCCCA TTGACGTCAA TGGGAGTTTG TTTTGGCACC 721 AAAATCAACG GGACTTTCCA AAATGTCGTA ACAACTCCGC CCCATTGACG CAAATGGGCG 781 GTAGGCGTGT ACGGTGGGAG GTCTATATAA GCAGAGCTCT CTGGCTAACT AGAGAACCCA 841 CTGCTTACTG GCTTATCGAA ATTAATACGA CTCACTATAG GGAGACCCAA GCTTGGTACC 901 GAGCTCGGAT CGATATCTGC GGCCTAGCTA GCGCTTAAGG CCTGTTAACC GGTCGTACGT 961 CTCCGGATTC GAATTCGGAT CCGCGGCCGC ATAGATAACT GATCCAGTGT GCTGGAATTA 1021 ATTCGCTGTC TGCGAGGGCC AGCTGTTGGG GTGAGTACTC CCTCTCAAAA GCGGGCATGA 1081 CTTCTGCGCT AAGATTGTCA GTTTCCAAAA ACGAGGAGGA TTTGATATTC ACCTGGCCCG 1141 CGGTGATGCC TTTGAGGGTG GCCGCGTCCA TCTGGTCAGA AAAGACAATC TTTTTGTTGT 1201 CAAGCTTGAG GTGTGGCAGG CTTGAGATCT GGCCATACAC TTGAGTGACA ATGACATCCA 1261 CTTTGCCTTT CTCTCCACAG GTGTCCACTC CCAGGTCCAA CTGCAGGTCG AGCATGCATC 1321 TAGGGCGGCC AATTCCGCCC CTCTCCCTCC CCCCCCCCTA ACGTTACTGG CCGAAGCCGC 1381 TTGGAATAAG GCCGGTGTGC GTTTGTCTAT ATGTTATTTT CCACCATATT GCCGTCTTTT 1441 GGCAATGTGA GGGCCCGGAA ACCTGGCCCT GTCTTCTTGA CGAGCATTCC TAGGGGTCTT 1501 TCCCCTCTCG CCAAAGGAAT GCAAGGTCTG TTGAATGTCG TGAAGGAAGC AGTTCCTCTG 1561 GAAGCTTCTT GAAGACAAAC AACGTCTGTA GCGACCCTTT GCAGGCAGCG GAACCCCCCA 1621 CCTGGCGACA GGTGCCTCTG CGGCCAAAAG CCACGTGTAT AAGATACACC TGCAAAGGCG 1681 GCACAACCCC AGTGCCACGT TGTGAGTTGG ATAGTTGTGG AAAGAGTCAA ATGGCTCTCC 1741 TCAAGCGTAT TCAACAAGGG GCTGAAGGAT GCCCAGAAGG TACCCCATTG TATGGGATCT 1801 GATCTGGGGC CTCGGTGCAC ATGCTTTACA TGTGTTTAGT CGAGGTTAAA AAAACGTCTA 1861 GGCCCCCCGA ACCACGGGGA CGTGGTTTTC CTTTGAAAAA CACGATGATA AGCTTGCCAC 1921 AACCCGGGAT AATTCCTGCA GCCAATATGG GATCGGCCAT TGAACAAGAT GGATTGCACG 1981 CAGGTTCTCC GGCCGCTTGG GTGGAGAGGC TATTCGGCTA TGACTGGGCA CAACAGACAA 2041 TCGGCTGCTC TGATGCCGCC GTGTTCCGGC TGTCAGCGCA GGGGCGCCCG GTTCTTTTTG 2101 TCAAGACCGA CCTGTCCGGT GCCCTGAATG AACTGCAGGA CGAGGCAGCG CGGCTATCGT 2161 GGCTGGCCAC GACGGGCGTT CCTTGCGCAG CTGTGCTCGA CGTTGTCACT GAAGCGGGAA 2221 GGGACTGGCT GCTATTGGGC GAAGTGCCGG GGCAGGATCT CCTGTCATCT CACCTTGCTC

2281 CTGCCGAGAA AGTATCCATC ATGGCTGATG CAATGCGGCG GCTGCATACG CTTGATCCGG 2341 CTACCTGCCC ATTCGACCAC CAAGCGAAAC ATCGCATCGA GCGAGCACGT ACTCGGATGG 2401 AAGCCGGTCT TGTCGATCAG GATGATCTGG ACGAAGAGCA TCAGGGGCTC GCGCCAGCCG 2461 AACTGTTCGC CAGGCTCAAG GCGCGCATGC CCGACGGCGA TGATCTCGTC GTGACCCATG 2521 GCGATGCCTG CTTGCCGAAT ATCATGGTGG AAAATGGCCG CTTTTCTGGA TTCATCGACT 2581 GTGGCCGGCT GGGTGTGGCG GACCGCTATC AGGACATAGC GTTGGCTACC CGTGATATTG 2641 CTGAAGAGCT TGGCGGCGAA TGGGCTGACC GCTTCCTCGT GCTTTACGGT ATCGCCGCTC 2701 CCGATTCGCA GCGCATCGCC TTCTATCGCC TTCTTGACGA GTTCTTCTGA GGGGATCAAT 2761 TCTCTAGATA ACTGATCATA ATCAGCCATA CCACATTTGT AGAGGTTTTA CTTGCTTTAA 2821 AAAACCTCCC ACACCTCCCC CTGAACCTGA AACATAAAAT GAATGCAATT GTTGTTGTTA 2881 ACTTGTTTAT TGCAGCTTAT AATGGTTACA AATAAAGCAA TAGCATCACA AATTTCACAA 2941 ATAAAGCATT TTTTTCACTG CATTCTAGTT GTGGTTTGTC CAAACTCATC AATGTATCTT 3001 AACGCGTCGA GTGCATTCTA GTTGTGGTTT GTCCAAACTC ATCAATGTAT CTTATCATGT 3061 CTGTATACCG TCGACCTCTA GCTAGAGCTT GGCGTAATCA TGGTCATAGC TGTTTCCTGT 3121 GTGAAATTGT TATCCGCTCA CAATTCCACA CAACATACGA GCCGGAAGCA TAAAGTGTAA 3181 AGCCTGGGGT GCCTAATGAG TGAGCTAACT CACATTAATT GCGTTGCGCT CACTGCCCGC 3241 TTTCCAGTCG GGAAACCTGT CGTGCCAGCT GCATTAATGA ATCGGCCAAC GCGCGGGGAG 3301 AGGCGGTTTG CGTATTGGGC GCTCTTCCGC TTCCTCGCTC ACTGACTCGC TGCGCTCGGT 3361 CGTTCGGCTG CGGCGAGCGG TATCAGCTCA CTCAAAGGCG GTAATACGGT TATCCACAGA 3421 ATCAGGGGAT AACGCAGGAA AGAACATGTG AGCAAAAGGC CAGCAAAAGG CCAGGAACCG 3481 TAAAAAGGCC GCGTTGCTGG CGTTTTTCCA TAGGCTCCGC CCCCCTGACG AGCATCACAA 3541 AAATCGACGC TCAAGTCAGA GGTGGCGAAA CCCGACAGGA CTATAAAGAT ACCAGGCGTT 3601 TCCCCCTGGA AGCTCCCTCG TGCGCTCTCC TGTTCCGACC CTGCCGCTTA CCGGATACCT 3661 GTCCGCCTTT CTCCCTTCGG GAAGCGTGGC GCTTTCTCAA TGCTCACGCT GTAGGTATCT 3721 CAGTTCGGTG TAGGTCGTTC GCTCCAAGCT GGGCTGTGTG CACGAACCCC CCGTTCAGCC 3781 CGACCGCTGC GCCTTATCCG GTAACTATCG TCTTGAGTCC AACCCGGTAA GACACGACTT 3841 ATCGCCACTG GCAGCAGCCA CTGGTAACAG GATTAGCAGA GCGAGGTATG TAGGCGGTGC 3901 TACAGAGTTC TTGAAGTGGT GGCCTAACTA CGGCTACACT AGAAGGACAG TATTTGGTAT 3961 CTGCGCTCTG CTGAAGCCAG TTACCTTCGG AAAAAGAGTT GGTAGCTCTT GATCCGGCAA 4021 ACAAACCACC GCTGGTAGCG GTGGTTTTTT TGTTTGCAAG CAGCAGATTA CGCGCAGAAA 4081 AAAAGGATCT CAAGAAGATC CTTTGATCTT TTCTACGGGG TCTGACGCTC AGTGGAACGA 4141 AAACTCACGT TAAGGGATTT TGGTCATGAG ATTATCAAAA AGGATCTTCA CCTAGATCCT 4201 TTTAAATTAA AAATGAAGTT TTAAATCAAT CTAAAGTATA TATGAGTAAA CTTGGTCTGA 4261 CAGTTACCAA TGCTTAATCA GTGAGGCACC TATCTCAGCG ATCTGTCTAT TTCGTTCATC 4321 CATAGTTGCC TGACTCCCCG TCGTGTAGAT AACTACGATA CGGGAGGGCT TACCATCTGG 4381 CCCCAGTGCT GCAATGATAC CGCGAGACCC ACGCTCACCG GCTCCAGATT TATCAGCAAT 4441 AAACCAGCCA GCCGGAAGGG CCGAGCGCAG AAGTGGTCCT GCAACTTTAT CCGCCTCCAT 4501 CCAGTCTATT AATTGTTGCC GGGAAGCTAG AGTAAGTAGT TCGCCAGTTA ATAGTTTGCG 4561 CAACGTTGTT GCCATTGCTA CAGGCATCGT GGTGTCACGC TCGTCGTTTG GTATGGCTTC 4621 ATTCAGCTCC GGTTCCCAAC GATCAAGGCG AGTTACATGA TCCCCCATGT TGTGCAAAAA 4681 AGCGGTTAGC TCCTTCGGTC CTCCGATCGT TGTCAGAAGT AAGTTGGCCG CAGTGTTATC 4741 ACTCATGGTT ATGGCAGCAC TGCATAATTC TCTTACTGTC ATGCCATCCG TAAGATGCTT 4801 TTCTGTGACT GGTGAGTACT CAACCAAGTC ATTCTGAGAA TAGTGTATGC GGCGACCGAG 4861 TTGCTCTTGC CCGGCGTCAA TACGGGATAA TACCGCGCCA CATAGCAGAA CTTTAAAAGT

4921 GCTCATCATT GGAAAACGTT CTTCGGGGCG AAAACTCTCA AGGATCTTAC CGCTGTTGAG 4981 ATCCAGTTCG ATGTAACCCA CTCGTGCACC CAACTGATCT TCAGCATCTT TTACTTTCAC 5041 CAGCGTTTCT GGGTGAGCAA AAACAGGAAG GCAAAATGCC GCAAAAAAGG GAATAAGGGC 5101 GACACGGAAA TGTTGAATAC TCATACTCTT CCTTTTTCAA TATTATTGAA GCATTTATCA 5161 GGGTTATTGT CTCATGAGCG GATACATATT TGAATGTATT TAGAAAAATA AACAAATAGG 5221 GGTTCCGCGC ACATTTCCCC GAAAAGTGCC ACCTGACGTC //

其他哺乳动物表达载体:pCHO1.0 pcDNA3.1/His C pcDNA3.1/His B pcDNA3.1/His A pIRESpuro3 pIRES2-EGFP pTT5

pNFkB-DD-tdTomato pBI-CMV5 pSEAP2-Basic pSEAP2-Control pBI-CMV3 pBI-CMV2 pBI-CMV1

pNF κB-MetLuc2-Reporter pCRE-MetLuc2-Reporter pAcGFP1-Actin

pAcGFP1-N In-Fusion Ready pAcGFP1-C3 pAcGFP1-C pAcGFP1-p53 pAcGFP1-Mito pAcGFP1-Mem pAcGFP1-Lam pAcGFP1-Golgi pAcGFP1-F pAcGFP1-Hyg-C1 pAsRed2-N1 ptdTomato-N1 pCMV-tdTomato pCRE-DD-tdTomato pCMV-DsRed-Express2 pEF1α-tdTomato pCRE-hrGFP

pBApo-CMV-Pur

pcDNA5/FRT/V5-His-TOPO pcDNA5/FRT/TO-TOPO pcDNA5/TO pcDNA5/FRT/TO pcDNA5/FRT pFLAG-CMV2

pcDNA3.1/CT-GFP-TOPO pcDNA3.1/NT-GFP-TOPO pOptiVEC-TOPO pCMV-MEKK1 pCMV-MEK1 pCMV-PKA

pcDNA6.2/nTC-Tag-DEST pcDNA6.2/cTC-Tag-DEST pcDNA3.2/V5/GW/D-TOPO pcDNA6.2/V5/GW/D-TOPO

pcDNA6.2/nGeneBLAzer-GW/D-TOPO pcDNA6.2/C-YFP-DEST pcDNA6.2/cGeneBLAzer-DEST pcDNA6/V5-His A pcDNA6/V5-His B pcDNA6/V5-His C pcDNA6/myc-His C pcDNA6/myc-His A pcDNA6/myc-His B

pcDNA6.2/nGeneBLAzer-DEST pcDNA4/HisMax-TOPO pcDNA6.2/nLumio-DEST pcDNA6.2/cLumio-DEST pcDNA4/myc-His C pcDNA4/HisMax C pcDNA4/HisMax A c-Flag pcDNA3

pOPRSVI pREP4 pDual-GC pBK-RSV pBK-CMV pBI-CMV4

pcDNA4/TO/Myc-His/LacZ pOPI3CAT pGene/V5-His B pSwitch pCMVLacI pVgRxR pIND pTRE3G-Luc pTRE3G pTRE2-hygro pTRE-Tight pTK-hyg pTet-On pTet-Off

pTet on advanced pRevTRE pRevTet-On pRevTet-Off pCMV-Tet3G pTRE2 pBD-NF-κB pCMV-AD pCMV-BD pBIND-Id Control pBIND pG5 luciferase pACT-MyoD pACT

ptdTomato-C1 pAsRed2-C1 pGL3-Promoter pGL3 basic pAcGFP1-C2 pAcGFP1-C1 pAcGFP1-N3 pAcGFP1-N2 pAcGFP1-N1

pAcGFP1-C In-Fusion Ready pCRE-DD-AmCyan1 pNFkB-DD-AmCyan1 pDsRed2-Bid pDsRED2-Mito

pDD-AmCyan1 Reporter pAmCyan1-N1 pAmCyan1-C1

pEF1α-IRES-DsRed-Express2 pEF1α-DsRed-Monomer-N1 pDsRED-Monomer-N1 pDsRed-Express-N1 p3XFLAG-CMV-7 pDsRed-Express-C1 pIRES2-ZsGreen1 pDsRed-Express2-C1 pDsRed-Express2-N1 pEF1α-DsRed-Express2 pIRES2-DsRed-Express pIRES2-DsRed-Express2 pIRES-hrGFP-1a pIRESneo2 pIRESneo pIREShyg3

pcDNA4/HisMax B pcDNA4/myc-His B pcDNA4/myc-His A pcDNA4/His C pcDNA4/His B pcDNA4/His A pcDNA6/TR

pcDNA4/TO/Myc-His A pcDNA4/TO

pcDNA4/TO/Myc-His B pcDNA4/TO/Myc-His C pcDNA3.3-TOPO pBudCE4.1 pFLAG-CMV-4 pFLAG-CMV-3 pFLAG-CMV-2 pFLAG-CMV-5a p3XFLAG-CMV-9 p3xFLAG-CMV-10 p3XFLAG-CMV-8 p3XFLAG-CMV-7.1

pDsRed-Monomer-N In-Fusion Ready p3XFLAG-CMV-13 p3XFLAG-CMV-14 plRES2-ZsGreen1 pBApo-EF1α-pur pBApo-EF1α-neo pBApo-CMV pBApo-CMV-neo pIRES-EGFP pIRESneo3 pDsRed-Monomer pIRES

pCMV-SPORT6 pGL4.13 pGL4.19 pGL4.26 pGL4.20 pGL4.29 pGL4.30 pGL4.27 pGL4.75 pGL4.10 pGRN145 pSecTag2 A pEBVHis B pEBVHis A pCMV-Tag 3C pCMV-Tag 3A pCMV-Tag 3B pCMV-Tag 5C pCMV-Tag 5A pCMV-Tag 4A pCMV-Tag 5B pCMV-Tag 4B pCMV-Tag 2C pCMV-Tag 2B pCMV-Tag 2A pCMV-LacZ pCMV-Myc

pEF1α-IRES-AcGFP1 pEF1α-IRES-ZsGreen1 pEF1α-AcGFP1-N1 pIRES2-DsRed2 pIRES2-AcGFP1

pIRESneo3

编号

北京华越洋生物VECT6018

pIRESneo 3载体基本信息

载体名称: 质粒类型: 启动子: 表达水平: 克隆方法: 载体大小: 5' 测序引物: 5' 测序引物序列: 3' 测序引物: 3' 测序引物序列:

载体标签: 载体抗性: 筛选标记: 克隆菌株: 宿主细胞(系):

备注: 稳定性: 组成型: 病毒/非病毒:

载体名称

pIRESneo3

pIRESneo3, pIRESneo 3 哺乳动物细胞表达载体 CMV 高

多克隆位点,限制性内切酶 5260bp CMV-F

5'-CGCAAATGGGCGGTAGGCGTG-3' pIRESrv

5'-GCCCTAGATGCATGCTCG-3' 无

氨苄青霉素(Ampicillin ) 新霉素(Neomycin ) DH5α, HB101

常规细胞系,293、CV-1、

CHO 等

pIRESneo3 contains the internal ribosome entry site (IRES) of the encephalomyocarditis virus (ECMV), which permits the translation of two open reading frames from one messenger RNA. 稳表达 或 瞬表达 组成型 非病毒

pIRESneo 3载体质粒图谱和多克隆位点信息

pIRESneo 3载体简介

Description: pIRESneo3

contains

the

internal

ribosome

entry

site

(IRES)

of

the

encephalomyocarditis virus (ECMV), which permits the translation of two open reading frames from one messenger RNA (1–3). After selection with G418, nearly all surviving colonies will stably express the gene of interest, thus decreasing the need to screen large numbers of colonies to find functional clones. To select for cells that express high levels of the gene of interest, the selective pressure for antibiotic resistance was increased by shifting the neomycin phosphotransferase gene downstream to a less optimal position for translation as directed by the IRES sequence (1). By decreasing the level of expression of the antibiotic resistance marker, the selective pressure on the entire expression cassette is increased, resulting in the selection of cells that express the entire transcript, including the gene of interest, at high levels.

The expression cassette of pIRESneo3 contains the human cytomegalovirus (CMV) major immediate early promoter/enhancer followed by a multiple cloning site (MCS) that precedes stop codons in all three reading frames, a synthetic intron known to enhance the stability of the mRNA (4), the ECMV IRES followed by the neomycin phosphotransferase (NPT II) gene, and the polyadenylation signal from SV40. Ribosomes can enter the bicistronic mRNA at the 5' end to translate the gene of interest and at the ECMV IRES to translate the antibiotic resistance marker. Use:

When using the pIRESneo3 Vector, the antibiotic exerts selective pressure on the entire expression cassette; thus, a high dose of antibiotic will select for cells expressing a high level of the gene of interest. This selective pressure also ensures that the expression of the gene of interest will be stable over time in culture. Unless your expression experiments require a pure population of cells, you can use the pool of cells surviving selection instead of isolating and characterizing clonal cell lines. We recommend selecting mammalian cultures in 500–1,300 µg/ml G418 (Cat. No. 631307) depending

on the cell line. Be sure to establish a kill curve for each cell line and each lot of G418 to determine optimal selection concentration.

pIRESneo 3载体序列

ORIGIN

1 GACGGATCGG GAGATCTCCC GATCCCCTAT GGTCGACTCT CAGTACAATC TGCTCTGATG 61 CCGCATAGTT AAGCCAGTAT CTGCTCCCTG CTTGTGTGTT GGAGGTCGCT GAGTAGTGCG 121 CGAGCAAAAT TTAAGCTACA ACAAGGCAAG GCTTGACCGA CAATTGCATG AAGAATCTGC 181 TTAGGGTTAG GCGTTTTGCG CTGCTTCGCG ATGTACGGGC CAGATATACG CGTTGACATT 241 GATTATTGAC TAGTTATTAA TAGTAATCAA TTACGGGGTC ATTAGTTCAT AGCCCATATA 301 TGGAGTTCCG CGTTACATAA CTTACGGTAA ATGGCCCGCC TGGCTGACCG CCCAACGACC 361 CCCGCCCATT GACGTCAATA ATGACGTATG TTCCCATAGT AACGCCAATA GGGACTTTCC 421 ATTGACGTCA ATGGGTGGAC TATTTACGGT AAACTGCCCA CTTGGCAGTA CATCAAGTGT 481 ATCATATGCC AAGTACGCCC CCTATTGACG TCAATGACGG TAAATGGCCC GCCTGGCATT 541 ATGCCCAGTA CATGACCTTA TGGGACTTTC CTACTTGGCA GTACATCTAC GTATTAGTCA 601 TCGCTATTAC CATGGTGATG CGGTTTTGGC AGTACATCAA TGGGCGTGGA TAGCGGTTTG 661 ACTCACGGGG ATTTCCAAGT CTCCACCCCA TTGACGTCAA TGGGAGTTTG TTTTGGCACC 721 AAAATCAACG GGACTTTCCA AAATGTCGTA ACAACTCCGC CCCATTGACG CAAATGGGCG 781 GTAGGCGTGT ACGGTGGGAG GTCTATATAA GCAGAGCTCT CTGGCTAACT AGAGAACCCA 841 CTGCTTACTG GCTTATCGAA ATTAATACGA CTCACTATAG GGAGACCCAA GCTTGGTACC 901 GAGCTCGGAT CGATATCTGC GGCCTAGCTA GCGCTTAAGG CCTGTTAACC GGTCGTACGT 961 CTCCGGATTC GAATTCGGAT CCGCGGCCGC ATAGATAACT GATCCAGTGT GCTGGAATTA 1021 ATTCGCTGTC TGCGAGGGCC AGCTGTTGGG GTGAGTACTC CCTCTCAAAA GCGGGCATGA 1081 CTTCTGCGCT AAGATTGTCA GTTTCCAAAA ACGAGGAGGA TTTGATATTC ACCTGGCCCG 1141 CGGTGATGCC TTTGAGGGTG GCCGCGTCCA TCTGGTCAGA AAAGACAATC TTTTTGTTGT 1201 CAAGCTTGAG GTGTGGCAGG CTTGAGATCT GGCCATACAC TTGAGTGACA ATGACATCCA 1261 CTTTGCCTTT CTCTCCACAG GTGTCCACTC CCAGGTCCAA CTGCAGGTCG AGCATGCATC 1321 TAGGGCGGCC AATTCCGCCC CTCTCCCTCC CCCCCCCCTA ACGTTACTGG CCGAAGCCGC 1381 TTGGAATAAG GCCGGTGTGC GTTTGTCTAT ATGTTATTTT CCACCATATT GCCGTCTTTT 1441 GGCAATGTGA GGGCCCGGAA ACCTGGCCCT GTCTTCTTGA CGAGCATTCC TAGGGGTCTT 1501 TCCCCTCTCG CCAAAGGAAT GCAAGGTCTG TTGAATGTCG TGAAGGAAGC AGTTCCTCTG 1561 GAAGCTTCTT GAAGACAAAC AACGTCTGTA GCGACCCTTT GCAGGCAGCG GAACCCCCCA 1621 CCTGGCGACA GGTGCCTCTG CGGCCAAAAG CCACGTGTAT AAGATACACC TGCAAAGGCG 1681 GCACAACCCC AGTGCCACGT TGTGAGTTGG ATAGTTGTGG AAAGAGTCAA ATGGCTCTCC 1741 TCAAGCGTAT TCAACAAGGG GCTGAAGGAT GCCCAGAAGG TACCCCATTG TATGGGATCT 1801 GATCTGGGGC CTCGGTGCAC ATGCTTTACA TGTGTTTAGT CGAGGTTAAA AAAACGTCTA 1861 GGCCCCCCGA ACCACGGGGA CGTGGTTTTC CTTTGAAAAA CACGATGATA AGCTTGCCAC 1921 AACCCGGGAT AATTCCTGCA GCCAATATGG GATCGGCCAT TGAACAAGAT GGATTGCACG 1981 CAGGTTCTCC GGCCGCTTGG GTGGAGAGGC TATTCGGCTA TGACTGGGCA CAACAGACAA 2041 TCGGCTGCTC TGATGCCGCC GTGTTCCGGC TGTCAGCGCA GGGGCGCCCG GTTCTTTTTG 2101 TCAAGACCGA CCTGTCCGGT GCCCTGAATG AACTGCAGGA CGAGGCAGCG CGGCTATCGT 2161 GGCTGGCCAC GACGGGCGTT CCTTGCGCAG CTGTGCTCGA CGTTGTCACT GAAGCGGGAA 2221 GGGACTGGCT GCTATTGGGC GAAGTGCCGG GGCAGGATCT CCTGTCATCT CACCTTGCTC

2281 CTGCCGAGAA AGTATCCATC ATGGCTGATG CAATGCGGCG GCTGCATACG CTTGATCCGG 2341 CTACCTGCCC ATTCGACCAC CAAGCGAAAC ATCGCATCGA GCGAGCACGT ACTCGGATGG 2401 AAGCCGGTCT TGTCGATCAG GATGATCTGG ACGAAGAGCA TCAGGGGCTC GCGCCAGCCG 2461 AACTGTTCGC CAGGCTCAAG GCGCGCATGC CCGACGGCGA TGATCTCGTC GTGACCCATG 2521 GCGATGCCTG CTTGCCGAAT ATCATGGTGG AAAATGGCCG CTTTTCTGGA TTCATCGACT 2581 GTGGCCGGCT GGGTGTGGCG GACCGCTATC AGGACATAGC GTTGGCTACC CGTGATATTG 2641 CTGAAGAGCT TGGCGGCGAA TGGGCTGACC GCTTCCTCGT GCTTTACGGT ATCGCCGCTC 2701 CCGATTCGCA GCGCATCGCC TTCTATCGCC TTCTTGACGA GTTCTTCTGA GGGGATCAAT 2761 TCTCTAGATA ACTGATCATA ATCAGCCATA CCACATTTGT AGAGGTTTTA CTTGCTTTAA 2821 AAAACCTCCC ACACCTCCCC CTGAACCTGA AACATAAAAT GAATGCAATT GTTGTTGTTA 2881 ACTTGTTTAT TGCAGCTTAT AATGGTTACA AATAAAGCAA TAGCATCACA AATTTCACAA 2941 ATAAAGCATT TTTTTCACTG CATTCTAGTT GTGGTTTGTC CAAACTCATC AATGTATCTT 3001 AACGCGTCGA GTGCATTCTA GTTGTGGTTT GTCCAAACTC ATCAATGTAT CTTATCATGT 3061 CTGTATACCG TCGACCTCTA GCTAGAGCTT GGCGTAATCA TGGTCATAGC TGTTTCCTGT 3121 GTGAAATTGT TATCCGCTCA CAATTCCACA CAACATACGA GCCGGAAGCA TAAAGTGTAA 3181 AGCCTGGGGT GCCTAATGAG TGAGCTAACT CACATTAATT GCGTTGCGCT CACTGCCCGC 3241 TTTCCAGTCG GGAAACCTGT CGTGCCAGCT GCATTAATGA ATCGGCCAAC GCGCGGGGAG 3301 AGGCGGTTTG CGTATTGGGC GCTCTTCCGC TTCCTCGCTC ACTGACTCGC TGCGCTCGGT 3361 CGTTCGGCTG CGGCGAGCGG TATCAGCTCA CTCAAAGGCG GTAATACGGT TATCCACAGA 3421 ATCAGGGGAT AACGCAGGAA AGAACATGTG AGCAAAAGGC CAGCAAAAGG CCAGGAACCG 3481 TAAAAAGGCC GCGTTGCTGG CGTTTTTCCA TAGGCTCCGC CCCCCTGACG AGCATCACAA 3541 AAATCGACGC TCAAGTCAGA GGTGGCGAAA CCCGACAGGA CTATAAAGAT ACCAGGCGTT 3601 TCCCCCTGGA AGCTCCCTCG TGCGCTCTCC TGTTCCGACC CTGCCGCTTA CCGGATACCT 3661 GTCCGCCTTT CTCCCTTCGG GAAGCGTGGC GCTTTCTCAA TGCTCACGCT GTAGGTATCT 3721 CAGTTCGGTG TAGGTCGTTC GCTCCAAGCT GGGCTGTGTG CACGAACCCC CCGTTCAGCC 3781 CGACCGCTGC GCCTTATCCG GTAACTATCG TCTTGAGTCC AACCCGGTAA GACACGACTT 3841 ATCGCCACTG GCAGCAGCCA CTGGTAACAG GATTAGCAGA GCGAGGTATG TAGGCGGTGC 3901 TACAGAGTTC TTGAAGTGGT GGCCTAACTA CGGCTACACT AGAAGGACAG TATTTGGTAT 3961 CTGCGCTCTG CTGAAGCCAG TTACCTTCGG AAAAAGAGTT GGTAGCTCTT GATCCGGCAA 4021 ACAAACCACC GCTGGTAGCG GTGGTTTTTT TGTTTGCAAG CAGCAGATTA CGCGCAGAAA 4081 AAAAGGATCT CAAGAAGATC CTTTGATCTT TTCTACGGGG TCTGACGCTC AGTGGAACGA 4141 AAACTCACGT TAAGGGATTT TGGTCATGAG ATTATCAAAA AGGATCTTCA CCTAGATCCT 4201 TTTAAATTAA AAATGAAGTT TTAAATCAAT CTAAAGTATA TATGAGTAAA CTTGGTCTGA 4261 CAGTTACCAA TGCTTAATCA GTGAGGCACC TATCTCAGCG ATCTGTCTAT TTCGTTCATC 4321 CATAGTTGCC TGACTCCCCG TCGTGTAGAT AACTACGATA CGGGAGGGCT TACCATCTGG 4381 CCCCAGTGCT GCAATGATAC CGCGAGACCC ACGCTCACCG GCTCCAGATT TATCAGCAAT 4441 AAACCAGCCA GCCGGAAGGG CCGAGCGCAG AAGTGGTCCT GCAACTTTAT CCGCCTCCAT 4501 CCAGTCTATT AATTGTTGCC GGGAAGCTAG AGTAAGTAGT TCGCCAGTTA ATAGTTTGCG 4561 CAACGTTGTT GCCATTGCTA CAGGCATCGT GGTGTCACGC TCGTCGTTTG GTATGGCTTC 4621 ATTCAGCTCC GGTTCCCAAC GATCAAGGCG AGTTACATGA TCCCCCATGT TGTGCAAAAA 4681 AGCGGTTAGC TCCTTCGGTC CTCCGATCGT TGTCAGAAGT AAGTTGGCCG CAGTGTTATC 4741 ACTCATGGTT ATGGCAGCAC TGCATAATTC TCTTACTGTC ATGCCATCCG TAAGATGCTT 4801 TTCTGTGACT GGTGAGTACT CAACCAAGTC ATTCTGAGAA TAGTGTATGC GGCGACCGAG 4861 TTGCTCTTGC CCGGCGTCAA TACGGGATAA TACCGCGCCA CATAGCAGAA CTTTAAAAGT

4921 GCTCATCATT GGAAAACGTT CTTCGGGGCG AAAACTCTCA AGGATCTTAC CGCTGTTGAG 4981 ATCCAGTTCG ATGTAACCCA CTCGTGCACC CAACTGATCT TCAGCATCTT TTACTTTCAC 5041 CAGCGTTTCT GGGTGAGCAA AAACAGGAAG GCAAAATGCC GCAAAAAAGG GAATAAGGGC 5101 GACACGGAAA TGTTGAATAC TCATACTCTT CCTTTTTCAA TATTATTGAA GCATTTATCA 5161 GGGTTATTGT CTCATGAGCG GATACATATT TGAATGTATT TAGAAAAATA AACAAATAGG 5221 GGTTCCGCGC ACATTTCCCC GAAAAGTGCC ACCTGACGTC //

其他哺乳动物表达载体:pCHO1.0 pcDNA3.1/His C pcDNA3.1/His B pcDNA3.1/His A pIRESpuro3 pIRES2-EGFP pTT5

pNFkB-DD-tdTomato pBI-CMV5 pSEAP2-Basic pSEAP2-Control pBI-CMV3 pBI-CMV2 pBI-CMV1

pNF κB-MetLuc2-Reporter pCRE-MetLuc2-Reporter pAcGFP1-Actin

pAcGFP1-N In-Fusion Ready pAcGFP1-C3 pAcGFP1-C pAcGFP1-p53 pAcGFP1-Mito pAcGFP1-Mem pAcGFP1-Lam pAcGFP1-Golgi pAcGFP1-F pAcGFP1-Hyg-C1 pAsRed2-N1 ptdTomato-N1 pCMV-tdTomato pCRE-DD-tdTomato pCMV-DsRed-Express2 pEF1α-tdTomato pCRE-hrGFP

pBApo-CMV-Pur

pcDNA5/FRT/V5-His-TOPO pcDNA5/FRT/TO-TOPO pcDNA5/TO pcDNA5/FRT/TO pcDNA5/FRT pFLAG-CMV2

pcDNA3.1/CT-GFP-TOPO pcDNA3.1/NT-GFP-TOPO pOptiVEC-TOPO pCMV-MEKK1 pCMV-MEK1 pCMV-PKA

pcDNA6.2/nTC-Tag-DEST pcDNA6.2/cTC-Tag-DEST pcDNA3.2/V5/GW/D-TOPO pcDNA6.2/V5/GW/D-TOPO

pcDNA6.2/nGeneBLAzer-GW/D-TOPO pcDNA6.2/C-YFP-DEST pcDNA6.2/cGeneBLAzer-DEST pcDNA6/V5-His A pcDNA6/V5-His B pcDNA6/V5-His C pcDNA6/myc-His C pcDNA6/myc-His A pcDNA6/myc-His B

pcDNA6.2/nGeneBLAzer-DEST pcDNA4/HisMax-TOPO pcDNA6.2/nLumio-DEST pcDNA6.2/cLumio-DEST pcDNA4/myc-His C pcDNA4/HisMax C pcDNA4/HisMax A c-Flag pcDNA3

pOPRSVI pREP4 pDual-GC pBK-RSV pBK-CMV pBI-CMV4

pcDNA4/TO/Myc-His/LacZ pOPI3CAT pGene/V5-His B pSwitch pCMVLacI pVgRxR pIND pTRE3G-Luc pTRE3G pTRE2-hygro pTRE-Tight pTK-hyg pTet-On pTet-Off

pTet on advanced pRevTRE pRevTet-On pRevTet-Off pCMV-Tet3G pTRE2 pBD-NF-κB pCMV-AD pCMV-BD pBIND-Id Control pBIND pG5 luciferase pACT-MyoD pACT

ptdTomato-C1 pAsRed2-C1 pGL3-Promoter pGL3 basic pAcGFP1-C2 pAcGFP1-C1 pAcGFP1-N3 pAcGFP1-N2 pAcGFP1-N1

pAcGFP1-C In-Fusion Ready pCRE-DD-AmCyan1 pNFkB-DD-AmCyan1 pDsRed2-Bid pDsRED2-Mito

pDD-AmCyan1 Reporter pAmCyan1-N1 pAmCyan1-C1

pEF1α-IRES-DsRed-Express2 pEF1α-DsRed-Monomer-N1 pDsRED-Monomer-N1 pDsRed-Express-N1 p3XFLAG-CMV-7 pDsRed-Express-C1 pIRES2-ZsGreen1 pDsRed-Express2-C1 pDsRed-Express2-N1 pEF1α-DsRed-Express2 pIRES2-DsRed-Express pIRES2-DsRed-Express2 pIRES-hrGFP-1a pIRESneo2 pIRESneo pIREShyg3

pcDNA4/HisMax B pcDNA4/myc-His B pcDNA4/myc-His A pcDNA4/His C pcDNA4/His B pcDNA4/His A pcDNA6/TR

pcDNA4/TO/Myc-His A pcDNA4/TO

pcDNA4/TO/Myc-His B pcDNA4/TO/Myc-His C pcDNA3.3-TOPO pBudCE4.1 pFLAG-CMV-4 pFLAG-CMV-3 pFLAG-CMV-2 pFLAG-CMV-5a p3XFLAG-CMV-9 p3xFLAG-CMV-10 p3XFLAG-CMV-8 p3XFLAG-CMV-7.1

pDsRed-Monomer-N In-Fusion Ready p3XFLAG-CMV-13 p3XFLAG-CMV-14 plRES2-ZsGreen1 pBApo-EF1α-pur pBApo-EF1α-neo pBApo-CMV pBApo-CMV-neo pIRES-EGFP pIRESneo3 pDsRed-Monomer pIRES

pCMV-SPORT6 pGL4.13 pGL4.19 pGL4.26 pGL4.20 pGL4.29 pGL4.30 pGL4.27 pGL4.75 pGL4.10 pGRN145 pSecTag2 A pEBVHis B pEBVHis A pCMV-Tag 3C pCMV-Tag 3A pCMV-Tag 3B pCMV-Tag 5C pCMV-Tag 5A pCMV-Tag 4A pCMV-Tag 5B pCMV-Tag 4B pCMV-Tag 2C pCMV-Tag 2B pCMV-Tag 2A pCMV-LacZ pCMV-Myc

pEF1α-IRES-AcGFP1 pEF1α-IRES-ZsGreen1 pEF1α-AcGFP1-N1 pIRES2-DsRed2 pIRES2-AcGFP1


相关内容

  • 生物选修3[专题一基因工程]教学设计
  • 专题一 1.1 DNA重组技术的基本工具 一.教材分析 < DNA重组技术的基本工具>是人教版生物选修三专题一<基因工程>的第一节,本节内容主要是介绍了DNA重组技术的三种基本工具,是学习<基因工程的基本操作程序>的基础和前提. 二.教学目标 1.知识目标: (1 ...

  • 基因工程试题及答案
  • 班 级:2006<基因工程原理>课程试题与答案 一.名词解释 1.寄主的修饰现象 寄主本身的DNA ,由于在合成后通过甲基化酶的作用得以甲基化,使DNA 得以修饰,从而免遭自身限制性酶的破坏. 2.F '细胞 以染色体外环双链质粒DNA 形式存在,同时还带有细菌色体基因或DNA 片段.这 ...

  • 基因工程试题与答案
  • 1.转基因动物的安全性问题 正面观点: (1)转基因工程是不可阻挡的. 基因工程将影响当代重大的环境问题:人口过剩/污染/生 物多样性急剧减退等等. 保护土壤/水/能源成为发展可持续农业的目标. (2) 转基因食品的功效: 改良植物的食用品质:增加果蔬贮藏.保鲜性能:生产特殊食 品--食品疫苗. ( ...

  • AAV自噬双标病毒产品说明-维真生物
  • VigenemCherry-GFP-LC3B 自噬双标腺相关病毒产品说明 一.关于自噬及LC3 1. 自噬 大自噬(macroautophagy ),也就是通常说的自噬(autophagy ),是真核细胞蛋白降解的途径之一.自噬可以被描述为细胞质内的成分(细胞器.蛋白等)被双层膜的囊泡包裹,形成自噬 ...

  • 转化,转染,转导,感染,中英双字幕解释
  • 转染和转化 转染的定义是"将具生物功能的核酸转移或运送到细胞内并使核酸在细胞内维持其生物功能".其中,核酸包括DNA (质粒和线性双链DNA ),反义寡核苷酸及RNAi (RNA interference ).基因转染技术已广泛应用于基因组功能研究(基因表达调控,基因功能,信号转 ...

  • 转染的步骤
  • 使用Lipofectamine2000转染Stealth RNA或者siRNA进入哺乳动物 Lipofectamine 2000试剂是一项专利配方,用于高效转染Stealth RNA或者短的干扰RNA(siRNA)到哺乳动物细胞,以进行RNAi分析(1,2).该说明书提供了一般的指导以及使用Lipo ...

  • 3生物选修三胚胎工程高考题汇编
  • 生物选修三胚胎工程高考题汇编 1.(09江苏8)下列关于哺乳动物胚胎发育和胚胎工程的叙述,正确的是 A.卵裂期胚胎中细胞数目和有机物总量在不断增加 B.胚胎分割时需将原肠胚的内细胞团均等分割 C.胚胎干细胞具有细胞核大.核仁小和蛋白质合成旺盛等特点 D.胚胎干细胞是一类未分化细胞,可从早期胚胎中分离 ...

  • 基因敲除)
  • 基因敲除技术的原理.方法和应用 1.基因敲除概述 2.实现基因敲除的多种原理和方法: 2.1.利用基因同源重组进行基因敲除 2.2利用随机插入突变进行基因敲除. 2.3.RNAi引起的基因敲除. 3.基因敲除技术的应用及前景 4.基因敲除技术的缺陷 关键词:基因敲除 1.基因敲除概述: 基因敲除是自 ...

  • 高二生物选修三基因工程测试题(含答案)
  • 基因工程测试题 姓名____________ 一.选择题 1.已知某种限制性内切酶在一线性DNA 分子上有3个酶切位点,如图中箭头所指,如果该线性DNA 分子在3个酶切位点上都被该酶切断,则会产生a .b .c .d 四种不同长度的DNA 片段.现在多个上述线性DNA 分子,若在每个DNA 分子上至 ...